loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2243856 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Knight Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TRIPTORELIN (TRIPTORELIN PAMOATE) (1)

    filter

    01 KNIGHT THERAPEUTICS INC. (1)

    filter

    01 POWDER FOR SUSPENSION, SUSTAINED-RELEASE (1)

    filter

    01 11.25MG/VIAL (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Triptorelin (triptorelin Pamoate)

      PDF Supplier PDF
      URL Supplier Web Content
      POWDER FOR SUSPENSION,...
      11.25MG/VIAL
      TRELSTAR
      Canada
      2243856
      Prescription
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 2243856

      Looking for CTD TGA MCC DOSSIER APPLICATION 2243856 1

      19

      Knight Therapeutics, based in Canada, is a pharmaceutical company.

      One of their notable products is TRIPTORELIN (TRIPTORELIN PAMOATE), with a corresponding application number 2243856 and regulatory information .

      proudly manufactured in the

      Knight Therapeutics's TRELSTAR POWDER FOR SUSPENSION, SUSTAINED-RELEASE, medication with 11.25MG/VIAL of TRIPTORELIN (TRIPTORELIN PAMOATE).

      Post Enquiry
      POST ENQUIRY